2009 annual financial data
BioCryst Pharmaceuticals 2009 Operating cash flow margin
Direct answer
Operating cash flow margin was -21.74%.
Operating income was -13,738,000 USD and net income was -13,452,000 USD.
Operating cash flow was -16,218,470 USD.
Get free BioCryst Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 74,589,000 USD
- Operating income
- -13,738,000 USD
- Net income
- -13,452,000 USD
- Operating cash flow
- -16,218,470 USD